Thailand FDA periodically releases list of of institutional review boards (IRBs) / ethics committees (ECs) that it recognizes for acceptance of clinical trials. Under Thailand regulatory system, approved ethics committees serve as the main point of approvals for initiating clinical trials in the country. This has been explained in our previous articles (see Part I and Part II), […]

Read More →

Taiwan is emerging as a big player in the Asian clinical trial market. There are many advantages of conducting clinical trials in Taiwan, which have been discussed in Part 1 of this blog. In this part, let’s talk a bit on the clinical trial regulatory scenario in Taiwan, including the approvals required and how to be prepared […]

Read More →

Recently, Thailand FDA has brought a revised list of institutional review boards (IRBs) / ethics committees (ECs) that it recognizes for acceptance of applications. In our previous articles (see Part I and Part II), we’ve discussed about the regulatory scenario in Thailand, including regulatory approvals for clinical trial in Thailand, ethics committee approval for clinical trial in Thailand, […]

Read More →

Taiwan has one of the most progressive healthcare systems in the world and is a major hub for clinical research in the Asia-Pacific region. Currently, it is well positioned to meet the growing demands of the global clinical trial market. Why choose Taiwan There are many good reasons to go to Taiwan for clinical trials. Here are […]

Read More →